Health Care Technology
Company Overview of SurgiQuest, Inc.
SurgiQuest, Inc. develops, manufactures, and markets technology solutions for minimally invasive surgery. It offers AirSeal, a dynamic pressure system technology used for general laparoscopic surgery; single port surgery; colorectal, gynecologic, urologic, and bariatric laparoscopy; endoluminal surgery; and transluminal surgery. The company also provides AnchorPort that provides clinical advantage for surgeons in the areas of colorectal, gynecologic, urologic, and bariatric laparoscopy; general laparoscopic surgery; single incision laparoscopy; and transluminal surgery. It serves clients in Australia, Austria, Chile, Japan, Italy, Jordan, Korea, Kuwait, the Netherlands, Qatar, Saudi Arabia, ...
333 Quarry Road
Milford, CT 06460
Founded in 2005
Key Executives for SurgiQuest, Inc.
Founder, Chief Executive Officer and Director
Senior Director of Operations
Vice President of Marketing & Sales
Compensation as of Fiscal Year 2015.
SurgiQuest, Inc. Key Developments
SurgiQuest, Inc. Airseal System Receive FDA 510(K) Clearance for Transanal Endoscopic Surgery
May 28 15
SurgiQuest, Inc. announced that its AirSeal System received 510(k) Clearance from the FDA for Transanal Endoscopic Surgery (TES). To date, the growth of transanal endoscopic surgery has been limited due to the technological constraints of conventional insufflation technology which is unable to provide a consistent, smoke-free working space. Because the AirSeal System ensures stable insufflation of the rectum and provides continuous smoke evacuation, surgeons can now perform TES with increased confidence, thus enabling faster adoption and proliferation within the global colorectal community. The category of transanal endoscopic surgery includes both transanal minimally invasive surgery (TAMIS) and transanal total mesorectal excision (TaTME), a surgical technique that has been shown to significantly improve patient outcomes in colorectal cancer procedures.
SurgiQuest, Inc. Names Jaime Landman, M.D. as Chief Medical Director
Apr 29 15
SurgiQuest, Inc. announced the appointment of Jaime Landman, M.D. as Chief Medical Director of the company. Dr. Landman is currently a Professor of Urology and Radiology and the Chairman of the Department of Urology at the University of California, Irvine School of Medicine.
SurgiQuest, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:30 AM
Dec 9 13
SurgiQuest, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Thomas Dugan, President and Chief Commercialization Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 10, 2015